Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
1 this month

Showing 4741–4760 of 17,529 recalls

April 13, 2021· Nomax Inc

Recalled Item: Dry Eye Test

The Issue: Subpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
April 12, 2021· Preferred Pharmaceuticals, Inc.

Recalled Item: Cephalexin for Oral Suspension

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 12, 2021· Edge Pharma, LLC

Recalled Item: Betadine (Povidone-Iodine) 5%

The Issue: Defective container; syringe content migrating past the seal

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 9, 2021· Teligent Pharma, Inc.

Recalled Item: Flurandrenolide Ointment USP

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 8, 2021· NSNY Distributor Inc

Recalled Item: Ginseng Power 5000 capsule

The Issue: Undeclared Sildenafil

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
April 8, 2021· NSNY Distributor Inc

Recalled Item: Premium OrgaZEN 7000 capsule

The Issue: Undeclared Sildenafil

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
April 6, 2021· Hyobin LLC

Recalled Item: PremierZen Black 5000

The Issue: Marketed without Approved NDA/ANDA: FDA analysis results obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 6, 2021· Hyobin LLC

Recalled Item: Triple SupremeZen Plus 3500

The Issue: Marketed without Approved NDA/ANDA: FDA analysis results obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 6, 2021· Hyobin LLC

Recalled Item: PremierZen Extreme 3000

The Issue: Marketed without Approved NDA/ANDA: FDA analysis results obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 1, 2021· Jubilant Cadista Pharmaceuticals, Inc.

Recalled Item: Itraconazole Capsules

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 31, 2021· QMart

Recalled Item: IMPERIAL GOLD 2000

The Issue: Marketed without Approved NDA/ANDA: FDA analysis results obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 31, 2021· QMart

Recalled Item: PremierZen Extreme 3000

The Issue: Marketed without Approved NDA/ANDA: FDA analysis results obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 31, 2021· QMart

Recalled Item: Imperial Platinum 2000

The Issue: Marketed without Approved NDA/ANDA: FDA analysis results obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 31, 2021· QMart

Recalled Item: Burro en Primavera

The Issue: Marketed without Approved NDA/ANDA: FDA analysis results obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 31, 2021· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Riomet (metformin hydrochloride oral solution) 500 mg/5 mL Cherry Flavor

The Issue: Microbial Contamination of Non-Sterile Product

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
March 31, 2021· Apotex Corp.

Recalled Item: Guanfacine Extended-Release Tablets 2 mg

The Issue: Cross Contamination with Other Product: Product is being

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
March 30, 2021· Ummzy, LLC

Recalled Item: Krazy Night capsule

The Issue: Undeclared Tadalafil

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
March 30, 2021· Ummzy, LLC

Recalled Item: Shogun-X capsules

The Issue: Undeclared Tadalafil

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
March 30, 2021· Ummzy, LLC

Recalled Item: Thumbs up 7 Red 70K capsules

The Issue: Undeclared Tadalafil

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
March 30, 2021· Na Na Collection

Recalled Item: Triple SupremeZen Gold 3500

The Issue: Marketed without Approved NDA/ANDA: FDA analysis results obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund